Newtyn Management, LLC

10% Owner
Newtyn Management, LLC
$347,265,000.00
%
COMPANY
SHARES
NET TOTAL
10.99%
PAR TECHNOLOGY CORP
1,018,068
$38,167,000.00
9.29%
BLUCORA INC
1,748,389
$32,275,000.00
7.80%
CANNAE HLDGS INC
1,400,000
$27,076,000.00
5.90%
SPECTRUM BRANDS HLDGS INC NE
249,937
$20,500,000.00
5.63%
MBIA INC
1,582,811
$19,548,000.00
5.32%
THERAVANCE BIOPHARMA INC
2,037,825
$18,463,000.00
4.08%
CITY OFFICE REIT INC
1,095,000
$14,180,000.00
3.83%
PFSWEB INC
1,131,505
$13,306,000.00
3.59%
ADIENT PLC
421,293
$12,483,000.00
3.20%
EPIZYME INC
7,569,995
$11,128,000.00
3.09%
LAMB WESTON HLDGS INC
150,000
$10,719,000.00
3.01%
MERRIMACK PHARMACEUTICALS IN
1,758,005
$10,460,000.00
2.91%
Other
6,300,485
$10,112,000.00
2.73%
GALAPAGOS NV
170,000
$9,486,000.00
2.69%
BRISTOW GROUP INC
398,745
$9,331,000.00
2.41%
PG&E CORP
840,000
$8,383,000.00
2.02%
AMPLIFY ENERGY CORP NEW
1,075,000
$7,031,000.00
1.97%
LIQUIDIA CORPORATION
1,568,627
$6,839,000.00
1.95%
VIRTUS INVT PARTNERS INC
39,500
$6,755,000.00
1.60%
KODIAK SCIENCES INC
725,000
$5,539,000.00
1.46%
CUSTOMERS BANCORP INC
150,000
$5,085,000.00
1.46%
UNIQURE NV
272,091
$5,072,000.00
1.25%
TILLYS INC
620,000
$4,352,000.00
1.19%
NEXPOINT DIVERSIFIED REL ET
250,000
$4,123,000.00
1.17%
STITCH FIX INC
825,000
$4,076,000.00
1.14%
RADIUS HEALTH INC
381,998
$3,961,000.00
0.88%
DESTINATION XL GROUP INC
900,000
$3,051,000.00
0.82%
DANIMER SCIENTIFIC INC
625,000
$2,850,000.00
0.70%
INTEVAC INC
504,035
$2,440,000.00
0.67%
COMPX INTL INC
100,000
$2,319,000.00
0.62%
PHATHOM PHARMACEUTICALS INC
255,767
$2,159,000.00
0.59%
OLEMA PHARMACEUTICALS INC
500,000
$2,035,000.00
0.58%
TCR2 THERAPEUTICS INC
692,799
$2,009,000.00
0.57%
CYTOMX THERAPEUTICS INC
1,073,400
$1,964,000.00
0.54%
COLLEGIUM PHARMACEUTICAL INC
105,000
$1,861,000.00
0.44%
BOLT BIOTHERAPEUTICS INC
748,252
$1,526,000.00
0.42%
PASSAGE BIO INC
620,000
$1,463,000.00
0.38%
WAVE LIFE SCIENCES LTD
403,553
$1,312,000.00
0.38%
DECIBEL THERAPEUTICS INC
310,000
$1,305,000.00
0.37%
BLACK DIAMOND THERAPEUTICS I
520,000
$1,279,000.00
0.36%
ADVERUM BIOTECHNOLOGIES INC
1,035,000
$1,242,000.00